SCHEMBL3129701

SCHEMBL3129701

CCOc1ccc(N(Cc2cnco2)c2cccc(C(=O)OC(C)(C)C)c2)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 2/20 0.40
NR1H2 P55055 2/20 0.37
NR1H3 Q13133 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
HRH4 Q9H3N8 1/20 0.36
TSHR P16473 2/20 0.36
AAK1 Q2M2I8 1/20 0.36
MAPK1 P28482 1/20 0.35
GPR119 Q8TDV5 1/20 0.35
MAPT P10636 4/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 1/20 0.35
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
IMPDH2 P12268 1/20 0.34
IMPDH1 P20839 1/20 0.34
BUB1 O43683 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3123133 0.97 SREBF1 (0.37) SREBF1NR1H2NR1H3L3MBTL1HRH4
SCHEMBL3255527 0.96 HRH4 (0.38) SREBF1NR1H2NR1H3L3MBTL1HRH4
SCHEMBL3215544 0.92 TSHR (0.40) SREBF1L3MBTL1HRH4TSHRAAK1
SCHEMBL3201229 0.89 TP53 (0.38) L3MBTL1HRH4TSHRAAK1MAPK1
SCHEMBL3130978 0.88 HRH4 (0.36) SREBF1NR1H2NR1H3HRH4TSHR
SCHEMBL3208802 0.88 TSHR (0.49) SREBF1L3MBTL1HRH4TSHRAAK1
SCHEMBL3207092 0.88 POLB (0.39) L3MBTL1TSHRAAK1GPR119MAPT
SCHEMBL3192199 0.87 HRH4 (0.39) L3MBTL1HRH4AAK1MAPK1GPR119
SCHEMBL3252850 0.87 GPR119 (0.35) SREBF1GPR119
SCHEMBL3205424 0.87 AAK1 (0.37) TSHRAAK1GPR119MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B SREBF1 4153/4885NR1H2 2403/4885NR1H3 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.